莫迪创投为投资技术生物融合领域筹集了8800万美元的第二支基金-动脉网

Modi Ventures Raises $88 Million for Second Fund to Invest in Tech Bio Convergence

CISION 等信源发布 2025-07-16 20:00



可切换为仅中文







Oversubscribed close brings total committed capital to over

超额认购使总承诺资本超过

$134 million

1.34亿美元

to invest in companies and funds at the intersection of tech, bio, and medicine

在科技、生物和医学交叉领域投资公司和基金

HOUSTON

休斯顿

，

July 16, 2025

2025年7月16日

/PRNewswire/ --

Modi Ventures,

莫迪创投，

a venture capital firm founded in 2022 that backs companies at the intersection of artificial intelligence, biology and medical technology, today announced the close of

一家成立于2022年的风险投资公司，支持处于人工智能、生物学和医疗技术交叉领域的公司，今天宣布结束

$88 million

8800万美元

of capital commitments with its second fund in an oversubscribed funding raise.

资本承诺的数额，其第二支基金在超额认购的募资中。

Modi Ventures is headquartered in the heart of

Modi Ventures 总部位于中心地带

Houston

休斯顿

with offices at the 37-acre TMC Helix Park campus within the Texas Medical Center (TMC), the world's largest medical ecosystem. Launched during a unique window of opportunity amid the market downturn of 2022, Modi Ventures swiftly raised over

办公室位于德克萨斯医疗中心（TMC）内37英亩的TMC Helix Park园区，这里是全球最大的医疗生态系统。Modi Ventures于2022年市场低迷期间的一个独特机遇中成立，迅速筹集了超过

$30 million

3000万美元

for its first fund in 2023. The firm has now closed its oversubscribed second fund in approximately three months, securing

为其2023年的第一支基金。该机构现已在大约三个月内完成了其超额认购的第二支基金，确保了

$88 million

8800万美元

. Using proprietary and innovative financial engineering, the fund is designed to select resilient portfolios, consisting of funds and companies, to navigate volatility, as demonstrated during its launch period.

通过使用专有且创新的金融工程技术，该基金旨在选择由基金和公司组成的弹性投资组合，以应对波动性，这在其推出期间已得到证明。

'Modi Ventures invests strategically at the convergence of technology and biology, employing a sophisticated and proprietary financial engineering framework rooted in modern portfolio theory and the efficient frontier principles,' said

“莫迪创投在技术与生物学的交汇点进行战略性投资，采用基于现代投资组合理论和有效前沿原则的复杂且专有的金融工程框架，”

Sahir Ali

萨希尔·阿里

, Modi Ventures' solo general partner. 'The second fund will continue to help build companies at the intersection of AI, biology, and medicine, focusing on pioneering advancements in digital biology and multi-omics, cellular reprogramming, AI-driven drug discovery, next-generation diagnostics, and therapeutics.'.

莫迪创投的唯一普通合伙人表示：“第二支基金将继续帮助处于人工智能、生物学和医学交叉领域的企业，聚焦数字生物学和多组学、细胞重编程、人工智能驱动的药物发现、下一代诊断和治疗等开创性进展。”

'We're proud to have witnessed the growth of Modi Ventures over the past few years at Helix Park, which is a cornerstone of Texas Medical Center's vision to create a globally recognized hub for translational research and innovation,' said

“我们很自豪过去几年在Helix Park见证了Modi Ventures的成长，这是德克萨斯医疗中心愿景的基石，旨在创建一个全球公认的转化研究和创新中心，”

William McKeon

威廉·麦克昂

, President and CEO of Texas Medical Center. 'We look forward to continuing our partnership as we work together to build a world-class life sciences ecosystem right here in

德克萨斯医学中心的总裁兼首席执行官。“我们期待继续我们的合作，因为我们共同努力在这里建立一个世界级的生命科学生态系统。

Houston

休斯顿

。

Initial investments include Lila Sciences, RTW Royalty Fund,

初始投资包括Lila Sciences、RTW Royalty Fund，

Ignota Labs

未知实验室

，

Latus Bio

拉图生物

and Flagship Pioneering.

和旗舰先锋。

About Modi Ventures

关于莫迪创投

Modi Ventures Capital Management, located in

莫迪风险资本管理公司，位于

Texas

德克萨斯州

and managing

以及管理

$134 million

1.34亿美元

, invests in innovators and companies shaping the future of humanity. The company's primary investment focus is on emerging and disruptive AI and biomedical technologies. Investments in successful funds include Khosla Ventures, Section 32, Artis Ventures, Draper Associates, Yosemite and Abingworth. Company investments and current holdings include Groq, Generate Biomedicines, Unnatural Products, Ozlo and Oklo.

，投资于塑造人类未来的创新者和公司。该公司主要的投资重点是新兴和颠覆性的人工智能及生物医学技术。成功基金的投资包括科斯拉风险投资公司（Khosla Ventures）、32区（Section 32）、艺术风险投资公司（Artis Ventures）、德雷珀联合（Draper Associates）、优胜美地（Yosemite）和阿宾沃斯（Abingworth）。公司的投资项目和当前持股包括Groq、Generate Biomedicines、Unnatural Products、Ozlo和Oklo。

For more information, please visit .

欲了解更多信息，请访问。

www.modivc.com

or follow us on

或关注我们

领英

。

Media Contacts:

媒体联系人：

Ignacio Guerrero-Ros

伊格纳西奥·格雷罗-罗斯

, Ph.D., or